Tracheal intubation with rocuronium using a "modified timing principle".

Area of Science:

• Anesthesiology
• Critical Care Medicine
• Emergency Medicine

Background:

• Rapid sequence induction (RSI) is a critical procedure in various medical situations.
• Succinylcholine is traditionally used for RSI, but rocuronium is an alternative for specific patient populations.
• Standard rocuronium dosing requires 60 seconds for adequate muscle relaxation, impacting RSI timing.

Purpose of the Study:

• To evaluate and compare intubating conditions using a modified timing principle for rocuronium versus conventional succinylcholine in RSI.
• To assess the efficacy and safety of rocuronium in RSI under specific timing protocols.

Main Methods:

• A prospective, controlled, blinded study involving patients undergoing RSI.
• Patients received fentanyl and preoxygenation, then were randomized to rocuronium (0.6 mg/kg) or succinylcholine (1.5 mg/kg).
• Intubation timing was immediate post-loss of consciousness for rocuronium and 1 minute post-injection for succinylcholine.

Main Results:

• All patients achieved successful intubation in both groups.
• Rocuronium group exhibited significantly shorter apnea time (38.5s) compared to succinylcholine (100.7s).
• No significant differences in loss of consciousness or intubation times; intubating conditions were comparable, with no awareness or postoperative respiratory issues.

Conclusions:

• Modified RSI with rocuronium provides a shorter intubation sequence compared to conventional succinylcholine RSI.
• Rocuronium demonstrates acceptable intubation conditions and a similar safety profile to succinylcholine.
• This modified approach offers a viable alternative for RSI, optimizing procedural efficiency.